Newcastle University

Publication:

Phase I studies with the nonclassical antifolate nolatrexed dihydrochloride (AG337, THYMITAQ) administered orally for 5 days (1999)

Author(s): Hughes, A. N., Rafi, I., Griffin, M. J., Calvert, A. H., Newell, D. R., Calvete, J., Johnston, A., Clendeninn, N., Boddy, A. V.

• Journal: Clinical Cancer Research
• Volume: 5
• Issue: 1
• Pages: 111-118
• Publication type: Article
• Bibliographic status: Published

• URL: http://clincancerres.aacrjournals.org/cgi/content/abstract/5/1/111
• PubMed id: 9918208
• ISSN (electronic): 1557-3265

Staff

Professor Alan Boddy Professor of Cancer Pharmacology

Email: alan.boddy@ncl.ac.uk Telephone: +44 (0) 191 246 4412